Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Denbury Inc.    DNRCQ

DENBURY INC.

(DNRCQ)
  Report
End-of-day quote. End-of-day quote OTC Bulletin Board - Other OTC - 09/18
0.03 USD   -4.46%
09/23DENBURY INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/23DENBURY : Change in Directors or Principal Officers (form 8-K/A)
AQ
09/22DENBURY RESOURCES : Emergence Presentation
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

DENBURY INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure (form 8-K)

share with twitter share with LinkedIn share with facebook
09/18/2020 | 05:06pm EDT

Item 1.01 - Entry into a Material Definitive Agreement

Reserve Based Revolving Credit Facility

On the Effective Date, pursuant to the terms of the Plan, Denbury, as borrower, the lenders party thereto (the "Lenders"), and JPMorgan Chase Bank, N.A., as administrative agent, swingline lender and the letter of credit issuer (the "Agent") entered into a reserve based revolving credit agreement (the "Exit Credit Facility") with aggregate commitments in the amount of $575.0 million. The initial borrowing base is $575.0 million until the next redetermination. The borrowing base will be redetermined semiannually on or around May 1 and November 1 of each year, with one interim "wildcard" redetermination available between scheduled redeterminations. The next scheduled redetermination will be on or around May 1, 2021. The initial availability under the Exit Credit Facility is $435 million on the Effective Date before giving effect to any outstanding letters of credit on such date.

The Exit Credit Facility provides for a $100.0 million sublimit of the aggregate commitments that is available for the issuance of letters of credit. The Exit Credit Facility bears interest either at a rate equal to (a) LIBOR plus an applicable margin that varies from 3.00% to 4.00% per annum or (b) a base rate plus an applicable margin that varies from 2.00% to 3.00% per annum. The Exit Credit Facility matures on January 30, 2024.

Denbury is required to pay a commitment fee of 0.50% per annum on the average daily unused portion of the current aggregate commitments under the Exit Credit Facility. Denbury is also required to pay customary letter of credit and fronting fees.

The Exit Credit Facility requires Denbury to maintain (i) a consolidated total leverage ratio of less than or equal to 3.50 to 1.00 and (ii) a consolidated current ratio of greater than or equal to 1.00 to 1.00.

The Exit Credit Facility also contains customary affirmative and negative covenants, including, among other things, as to compliance with laws (including environmental laws and anti-corruption laws), delivery of quarterly and annual financial statements, conduct of business, maintenance of property, maintenance of insurance, restrictions on the incurrence of liens,



                                       2

--------------------------------------------------------------------------------

indebtedness, investments, asset dispositions, fundamental changes, restricted payments, transactions with affiliates, and other customary covenants.

Additionally, the Exit Credit Facility contains customary events of default and remedies for credit facilities of this nature. If Denbury does not comply with the financial and other covenants in the Exit Credit Facility, the Lenders may, subject to customary cure rights, require immediate payment of all amounts outstanding under the Exit Credit Facility and any outstanding unfunded commitments may be terminated.

This summary is qualified in its entirety by reference to the full text of the Exit Credit Facility, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.

Guarantee and Security of the Exit Credit Facility

The obligations under the Exit Credit Facility are guaranteed by certain of . . .

Item 1.02 - Termination of a Material Definitive Agreement

Equity Interests

In accordance with the Plan, all agreements, instruments and other documents evidencing, relating to or otherwise connected with any of Legacy Denbury's equity interests outstanding prior to the Effective Date were cancelled and all such equity interests have no further force or effect after the Effective Date. Pursuant to the Plan, the holders of Legacy Denbury's existing common stock, par value $0.001 (the "Existing Equity Interests"), outstanding prior to the Effective Date received their pro rata share of 45.45% of the Series B Warrants to acquire the New Common Stock.

Debt Securities

In accordance with the Plan, on the Effective Date, all outstanding obligations under the following notes issued by Legacy Denbury and the related registration rights were cancelled and the indentures governing such obligations were cancelled, except to the limited extent expressly set forth in the Plan:

•      9% Senior Secured Second Lien Notes due 2021 (the "2021 Notes"), issued
       under the Indenture, dated as of May 10, 2016, as supplemented by that
       First Supplemental Indenture, dated as of September 8, 2017 and as further
       supplemented by that Second Supplemental Indenture, dated as of July 27,
       2018.


•      9¼% Senior Secured Second Lien Notes due 2022 (the "2022 Notes"), issued
       under the Indenture, dated as of December 6, 2017, as supplemented by that
       First Supplemental Indenture, dated as of July 27, 2018.


•      7½% Senior Secured Second Lien Notes due 2024 (the "2024 Notes"), issued
       under the Indenture, dated as of August 21, 2018.


•      7¾% Senior Secured Second Lien Notes due 2024 (together with the 2021
       Notes, the 2022 Notes and the 2024 Notes, the "Second Lien Notes"), issued
       under the Indenture, dated as of June 19, 2019.


•      6?% Convertible Senior Notes due 2024 (the "Convertible Notes"), issued
       under the Indenture, dated as of June 19, 2019.


•      6?% Senior Subordinated Notes due 2021 (the "Subordinated 2021 Notes"),
       issued under the Indenture, dated as of February 17, 2011, as supplemented
       by that First Supplemental Indenture, dated as of December 31, 2014, as
       further supplemented by that Second Supplemental Indenture, dated as of
       September 8, 2017 and as further supplemented by that Third Supplemental
       Indenture, dated as of July 27, 2018.




                                       4

--------------------------------------------------------------------------------

•      5½% Senior Subordinated Notes due 2022 (the "Subordinated 2022 Notes"),
       issued under the Indenture, dated as of April 30, 2014, as supplemented by
       that First Supplemental Indenture, dated as of December 31, 2014, as
       further supplemented by that Second Supplemental Indenture, dated as of
       September 8, 2017 and as further supplemented by that Third Supplemental
       Indenture, dated as of July 27, 2018.


•      4?% Senior Subordinated Notes due 2023 (together with the Subordinated
       2021 Notes and the Subordinated 2022 Notes, the "Subordinated Notes"),
. . .

Item 2.03 - Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

On the Effective Date, the Company entered into certain direct financial obligations under the Exit Credit Facility. The description of the Exit Credit Facility set forth in Item 1.01 of this Current Report is incorporated herein by reference.

Item 3.02 - Unregistered Sales of Equity Securities

On the Effective Date, pursuant to the Plan:

•      47,499,999 shares of New Common Stock were issued pro rata to holders of
       the Second Lien Notes;


•      2,500,000 shares of New Common Stock and 2,631,579 Series A Warrants to
       purchase 2,631,579 shares of New Common Stock were issued to the holders
       of the Convertible Notes;




                                       5

--------------------------------------------------------------------------------

•      1,578,947 Series B Warrants to purchase 1,578,947 shares of New Common
       Stock were issued pro rata to holders of the Subordinated Notes; and


•      1,315,793 Series B Warrants to purchase 1,315,793 shares of New Common
       Stock were issued pro rata to holders of the Existing Equity Interests.
       Shares of the Existing Equity Interests were converted into Series B
       Warrants at an effective exchange ratio of 0.00259485 per existing common
       share.


As of the Effective Date, there were 49,999,999 shares of New Common Stock issued and outstanding.

The New Common Stock and Warrants were issued pursuant to the Plan and were issued pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), under Section 1145 of the Bankruptcy Code.

Item 3.03 - Material Modifications to Rights of Security Holders

As provided in the Plan, all notes, equity, agreements, instruments, certificates and other documents evidencing any claim against or interest in the Company were cancelled on the Effective Date and the obligations of the Company thereunder or in any way related thereto were fully released. The securities to be cancelled on the Effective Date include all of the Second Lien Notes, the Convertible Notes, the Subordinated Notes and the Existing Equity Interests. For further information, see the Explanatory Note and Items 1.02 and 5.03 of this Current Report, which are incorporated herein by reference.

Item 5.01 - Changes in Control of Registrant

As previously disclosed, on the Effective Date, all of the Second Lien Notes, the Convertible Notes, the Subordinated Notes and the Existing Equity Interests were cancelled, and Denbury issued approximately 95% of the New Common Stock to holders of the Second Lien Notes and approximately 5% of the New Common Stock to holders of the Convertible Notes. For further information, see Items 1.02, 3.02 and 5.02 of this Current Report, which are incorporated herein by reference.

Item 5.02 - Departure of Directors; Election of Directors

Departure of Directors

In accordance with the Plan, Michael B. Decker, John P. Dielwart, Gregory L. McMichael, Randy Stein and Mary M. VanDeWeghe resigned from the Legacy Denbury board of directors (the "Legacy Denbury Board") on the Effective Date. There were no known disagreements between such directors and Legacy Denbury which led to their respective resignations from the Legacy Denbury Board.

Appointment of Directors

As of the Effective Date, by operation of and in accordance with the Plan, the Denbury board of directors (the "Board") consists of seven members, comprised of three members of the pre-Effective Date Legacy Denbury Board and four new members selected in accordance with the Plan. As of the Effective Date, by operation of and in accordance with the Plan, the following individuals were appointed to the Board: Anthony Abate, Caroline Angoorly, Brett Wiggs and James R. "Jim" Chapman. Dr. Kevin O. Meyers, Lynn A. Peterson and Chris Kendall, Denbury's President and Chief Executive Officer, will continue to serve as directors. The Board consists of a single class of directors with the initial term of office to expire at the 2021 annual meeting of stockholders and then at the next succeeding annual meeting of stockholders thereafter or the date on which the successor of such director is elected.

The current expected committees of the Board and directors appointed to each committee are as follows:

• Audit Committee: Mr. Abate (Chair), Dr. Meyers and Mr. Wiggs.

• Compensation Committee: Mr. Chapman (Chair), Mr. Abate and Mr. Peterson.


•      Nominating/Corporate Governance Committee: Mr. Peterson (Chair), Ms.
       Angoorly and Mr. Chapman.


In connection with their appointment, Mr. Peterson, Dr. Meyers, Mr. Abate, Mr. Chapman, Ms. Angoorly and Mr. Wiggs will each enter into an indemnification agreement with the Company providing for indemnification and advancement of litigation and other expenses to the fullest extent permitted by law for claims relating to their service to the Company or its subsidiaries. This



                                       6

--------------------------------------------------------------------------------

summary is qualified in its entirety by reference to the full text of the Company's form of indemnification agreement, which is attached hereto as Exhibit 10.5 and incorporated by reference herein.

There is no other arrangement or understanding between Mr. Peterson, Dr. Meyers, Mr. Abate, Mr. Chapman, Ms. Angoorly and Mr. Wiggs and any other persons pursuant to which he or she was appointed as a member of the Board. Mr. Peterson, Dr. Meyers, Mr. Abate, Mr. Chapman, Ms. Angoorly and Mr. Wiggs do not have any family relationship with any director or executive officer of the Company. There is no relationship between Mr. Peterson, Dr. Meyers, Mr. Abate, Mr. Chapman, Ms. Angoorly and Mr. Wiggs and the Company that would require disclosure pursuant to Item 404(a) of Regulation S-K.

Management Incentive Plan

In accordance with the Plan, the Board is adopting a Management Incentive Plan (the "MIP") effective as of the Effective Date. The MIP will be effectuated by amending and restating the Denbury Resources Inc. Amended and Restated 2004 Omnibus Stock and Incentive Plan, as amended and restated as of March 28, 2019, which will provide for, among other things, the grant of incentive stock options, nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights, dividend equivalents, other stock-based awards, cash awards, performance awards or any combination of the foregoing. Pursuant to the MIP, Denbury is reserving for employees, directors and other service providers a pool of shares of New Common Stock representing up to 10% of the New Common Stock, determined on a fully diluted and fully distributed basis.

Item 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On the Effective Date, in accordance with the Plan, Denbury filed the Third Restated Certificate of Incorporation (the "Certificate of Incorporation") with the Delaware secretary of state. Also on the Effective Date, in accordance with the Plan, Denbury adopted the Fourth Amended and Restated Bylaws (the "Bylaws").

Pursuant to the Certificate of Incorporation, the authorized capital stock of Denbury consists of 250,000,000 shares of New Common Stock and 50,000,000 shares of preferred stock, par value $0.001 per share.

Each holder of shares of New Common Stock, as such, shall be entitled to one vote for each share of New Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote. Except as otherwise required by law or provided in the Certificate of Incorporation, at any annual or special meeting of stockholders, the New Common Stock shall have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders.

Subject to the rights of any then-outstanding shares of preferred stock, the holders of New Common Stock may receive such dividends as the Board may declare in its discretion out of legally available funds at any regular or special meeting. Holders of New Common Stock will share equally in Denbury's assets upon liquidation after payment or provision for all liabilities and any preferential liquidation rights of any preferred stock then outstanding. Shares of New Common Stock are not subject to any redemption provisions and are not convertible into any of Denbury's other securities.

Preferred Stock

Shares of preferred stock may be issued in one or more series from time to time, with each such series to consist of such number of shares and to have such powers, designations, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, if any, as shall be stated in the resolution or resolutions providing for the issuance of such series adopted by the Board.

It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of holders of Denbury's common stock until the Board determines the specific rights of the holders of the preferred stock. However, these effects might include:

• restricting dividends on the common stock;

• diluting the voting power of the common stock;

• impairing the liquidation rights of the common stock; and

• delaying or preventing a change in control of Denbury.



Anti-Takeover Provisions



                                       7

--------------------------------------------------------------------------------

Some provisions of Delaware law, the Certificate of Incorporation and the Bylaws summarized below could make certain change of control transactions more difficult, including acquisitions of Denbury by means of a tender offer, proxy contest or otherwise, as well as removal of the incumbent directors. These provisions may have the effect of preventing changes in management. It is possible that these provisions would make it more difficult to accomplish or deter transactions that a stockholder might consider in his or her best interest, including those attempts that might result in a premium over the market price for the New Common Stock.

Business Combinations under Delaware Law

Denbury is not governed by Section 203 of the Delaware General Corporation Law (the "DGCL").

Number and Election of Directors

The Board shall consist of not less than three nor more than fifteen members, the exact number of which shall be determined from time to time by resolution adopted by a majority of the Board.

Calling of Special Meeting of Stockholders

The Bylaws provide that special meetings of stockholders may be called only by (i) a majority of the Board or (ii) the secretary of Denbury upon the delivery of a written request to Denbury by the holders who own at least 25% of the aggregate voting power of the then issued and outstanding shares of capital stock of Denbury.

Amendments to the Bylaws

The Bylaws may be altered, amended or repealed or new bylaws may be adopted (i) by action of the majority of the Board or (ii) without action of the Board, (x) at a duly called meeting of the stockholders by the affirmative vote of the holders of a majority of Shares having voting power present in person or represented by proxy at such meeting at which a quorum is present, or (y) by written consent of stockholders holding not less than a majority of the voting power of all outstanding shares of capital stock entitled to vote generally in the election of directors.

Other Limitations on Stockholder Actions

Advance notice is required for stockholders to nominate directors or to submit proposals for consideration at meetings of stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to the corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice of stockholder proposals relating to an annual meeting must be received at the principal executive offices not less than 90 days nor more than 120 days prior to the date of the one-year anniversary of the immediately preceding annual meeting of stockholders. The Bylaws specify in detail the requirements as to form and content of all stockholder notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting. The Bylaws also describe certain criteria for when stockholder-requested meetings need not be held.

Directors may be removed from office at any time by the affirmative vote of holders of at least a majority of the outstanding shares of capital stock entitled generally to vote in the election of directors.

Newly Created Directorships and Vacancies on the Board

Under the Bylaws, any newly created directorships resulting from any vacancies on the Board for any reason may be filled solely by a majority vote of the directors then in office, even if less than a quorum, or by a sole remaining director, and any newly created directorships resulting from any increase in the number of directors may be filled solely by a majority vote of the directors then in office, or if not so filled, by the stockholders at the next duly called annual meeting or special meeting called for such purpose.

No Cumulative Voting

The Certificate of Incorporation provides that there will be no cumulative voting in the election of directors.

Authorized but Unissued Shares




                                       8

--------------------------------------------------------------------------------

Under Delaware law, Denbury's authorized but unissued shares of New Common Stock are available for future issuance without stockholder approval. Denbury may use these additional shares of New Common Stock for a variety of corporate purposes, including future public offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued shares of New Common Stock could render more difficult or discourage an attempt to obtain control of Denbury by means of a proxy contest, tender offer, merger or otherwise.

Exclusive Forum

The Certificate of Incorporation provides that, unless Denbury consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (the "Court of Chancery") (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, a state or federal court located within the State of Delaware) and any appellate court therefrom shall, to the fullest extent permitted by law, will be the sole and exclusive forum for (i) any derivative action, suit or proceeding brought on . . .

Item 7.01 - Regulation FD Disclosure

On the Effective Date, the Company issued a press release on September 18, 2020, a copy of which is attached to this Form 8-K as Exhibit 99.2.

The information contained in this Item 7.01, including in Exhibit 99.2, shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.





                                       10

--------------------------------------------------------------------------------

Item 9.01 - Financial Statements and Exhibits

(d) Exhibits.




The following exhibits are filed in accordance with the provisions of Item 601
of Regulation S-K:
Exhibit
Number       Description
  2.1          Joint Chapter 11 Plan of Reorganization of Denbury Resources Inc.
             and its Debtor Affiliates (Technical Modifications) (incorporated by
             reference to Exhibit A of the Order Approving the Debtors'
             Disclosure Statement For, and Confirming, the Debtors' Joint Chapter
             11 Plan of Reorganization of Denbury Resources Inc. and its Debtor
             Affiliates, filed as Exhibit 2.1 to Denbury's Current Report on Form
             8-K filed on September 4, 2020).
 3.1*          Third Restated Certificate of Incorporation of Denbury Resources
             Inc.
 3.2*          Fourth Amended and Restated Bylaws of Denbury Inc.
10.1* †        Credit Agreement, dated as of September 18, 2020, by and among
             Denbury Inc., as borrower, the lenders party thereto, and JPMorgan
             Chase Bank, N.A., as administrative agent, swingline lender, and
             letter of credit issuer.
 10.2*         Series A Warrant Agreement, dated as of September 18, 2020, by and
             between Denbury Inc., and Broadridge Corporate Issuer Solutions,
             Inc.
 10.3*         Series B Warrant Agreement, dated as of September 18, 2020, by and
             between Denbury Inc., and Broadridge Corporate Issuer Solutions,
             Inc.
 10.4*         Registration Rights Agreement, dated as of September 18, 2020, by
             and between the Denbury Inc. and the holders party thereto.
 10.5*         Form of Indemnification Agreement, by and between Denbury Inc. and
             its officers and directors.
 99.1          Order Approving the Debtors' Disclosure Statement for, and
             Confirming, the Debtors' Joint Chapter 11 Plan of Reorganization of
             Denbury Resources Inc. and its Debtor Affiliates (incorporated by
             reference to Exhibit 99.1 to Denbury Resources Inc.'s Current Report
             on Form 8-K filed on September 4, 2020).
 99.2*         Denbury Press Release, dated September 18, 2020.
  104        The cover page has been formatted in Inline XBRL.



* Included herewith.


†      Certain schedules and similar attachments have been omitted pursuant to
       Item 601(a)(5) of Regulation S-K and will be provided to the SEC upon
       request.






                                       11

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about DENBURY INC.
09/23DENBURY INC : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
09/23DENBURY : Change in Directors or Principal Officers (form 8-K/A)
AQ
09/22DENBURY RESOURCES : Emergence Presentation
PU
09/21DENBURY RESOURCES : Successfully Completes Financial Restructuring
PU
09/18DENBURY INC : Entry into a Material Definitive Agreement, Termination of a Mater..
AQ
09/18DENBURY RESOURCES : Successfully Completes Financial Restructuring
AQ
09/15DENBURY RESOURCES INC : Other Events (form 8-K)
AQ
09/04NEWS HIGHLIGHTS : Top Energy News of the Day
DJ
09/04NEWS HIGHLIGHTS : Top Energy News of the Day
DJ
09/04NEWS HIGHLIGHTS : Top Energy News of the Day
DJ
More news